Zuclomiphene citrate
Cat. No.：YN482051
| 产品名称: | Zuclomiphene citrate |
| CAS No.: | 7619-53-6 |
| Chemical Name: | (Z)-2-[4-(2-chloro-1,2-diphenylethenyl)phenoxy]-N,N-diethyl-ethanamine 2-Hydroxy-1,2,3-propanetricarboxylate (1:1); (Z)-2-[p-(2-chloro-1,2-diphenylvinyl)phenoxy]triethylamine Citrate (1:1); (Z)-Clomiphene Citrate; Clomiphene A Citrate; NSC 151466; Zuclomi |
| Synonyms: | |
| 分子量: | 598.08 |
| 分子式: | C₃₂H₃₆ClNO₈ |
| SMILES: | Cl/C(C1=CC=CC=C1)=C(C2=CC=C(OCCN(CC)CC)C=C2)/C3=CC=CC=C3.O=C(CC(C(O)=O)(O)CC(O)=O)O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Zuclomiphene citrate 是柠檬酸克罗米芬的顺式异构体。Zuclomiphene citrate 具有抗雌激素的作用，比反式异构体更能抑制黄体生成激素 (LH) 的分泌。Zuclomiphene citrate 也是一种口服活性降胆固醇剂。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Robert, B.S.: J. Anim. Sci., 33, 607 (1971)
Weissenberg, R.: Andrologia, 24, 162 (1992)
Palopoli, F.P., J. Med. Chem., 10, 84 (1967)
Ernst., et al.: J. Pharm. Sci., 65, 148 (1976)
Baustian, C.L., et al.: Pharm. Biomed. Anal., 4, 237 (1986)
